PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

NCT07142291 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Cromolyn Sodium (34.2 mg BID)
DRUG: Cromolyn Sodium (17.1 mg BID)
DRUG: Placebo
DRUG: Riluzole (100 mg)

Sponsor

PhenoNet, Inc.